117 related articles for article (PubMed ID: 20553980)
1. Accumulation of polyubiquitylated proteins in response to Ala-Ala-Phe-chloromethylketone is independent of the inhibition of Tripeptidyl peptidase II.
Villasevil EM; Guil S; López-Ferreras L; Sánchez C; Del Val M; Antón LC
Biochim Biophys Acta; 2010 Sep; 1803(9):1094-105. PubMed ID: 20553980
[TBL] [Abstract][Full Text] [Related]
2. Semispecific TPPII inhibitor Ala-Ala-Phe-chloromethylketone (AAF-cmk) displays cytotoxic activity by induction of apoptosis, autophagy and protein aggregation in U937 cells.
Bialy LP; Fayet J; Wilczynski GM; Mlynarczuk-Bialy I
Folia Histochem Cytobiol; 2018; 56(4):185-194. PubMed ID: 30294774
[TBL] [Abstract][Full Text] [Related]
3. Tripeptidyl peptidase II is dispensable for the generation of both proteasome-dependent and proteasome-independent ligands of HLA-B27 and other class I molecules.
Marcilla M; Villasevil EM; de Castro JA
Eur J Immunol; 2008 Mar; 38(3):631-9. PubMed ID: 18286573
[TBL] [Abstract][Full Text] [Related]
4. Effects of an inhibitor of tripeptidyl peptidase II (Ala-Ala-Phe-chloromethylketone) and its combination with an inhibitor of the chymotrypsin-like activity of the proteasome (PSI) on apoptosis, cell cycle and proteasome activity in U937 cells.
Bury M; Młynarczuk I; Pleban E; Hoser G; Kawiak J; Wójcik C
Folia Histochem Cytobiol; 2001; 39(2):131-2. PubMed ID: 11374791
[TBL] [Abstract][Full Text] [Related]
5. Tripeptidyl peptidase II serves as an alternative to impaired proteasome to maintain viral growth in the host cells.
Zhang J; Wong J; Gao G; Luo H
FEBS Lett; 2011 Jan; 585(1):261-5. PubMed ID: 21134372
[TBL] [Abstract][Full Text] [Related]
6. Tripeptidyl peptidase II promotes maturation of caspase-1 in Shigella flexneri-induced macrophage apoptosis.
Hilbi H; Puro RJ; Zychlinsky A
Infect Immun; 2000 Oct; 68(10):5502-8. PubMed ID: 10992446
[TBL] [Abstract][Full Text] [Related]
7. Changes in spatio-temporal localization of tripeptidyl peptidase II (TPPII) in murine colon adenocarcinoma cells during aggresome formation: a microscopy study based on a novel fluorescent proteasome inhibitor.
Bialy LP; Kuckelkorn U; Henklein P; Fayet J; Wilczyński GM; Kamiński A; Mlynarczuk-Bialy I
Histol Histopathol; 2019 Apr; 34(4):359-372. PubMed ID: 30226264
[TBL] [Abstract][Full Text] [Related]
8. Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival.
Princiotta MF; Schubert U; Chen W; Bennink JR; Myung J; Crews CM; Yewdell JW
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):513-8. PubMed ID: 11149939
[TBL] [Abstract][Full Text] [Related]
9. Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle.
Chand A; Wyke SM; Tisdale MJ
Cancer Lett; 2005 Feb; 218(2):215-22. PubMed ID: 15670899
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
Scand J Immunol; 2008 Dec; 68(6):579-88. PubMed ID: 19000094
[TBL] [Abstract][Full Text] [Related]
11. The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases.
Lévy F; Burri L; Morel S; Peitrequin AL; Lévy N; Bachi A; Hellman U; Van den Eynde BJ; Servis C
J Immunol; 2002 Oct; 169(8):4161-71. PubMed ID: 12370345
[TBL] [Abstract][Full Text] [Related]
12. Is there an alternative to the proteasome in cytosolic protein degradation?
Antón LC; Villasevil EM
Biochem Soc Trans; 2008 Oct; 36(Pt 5):839-42. PubMed ID: 18793147
[TBL] [Abstract][Full Text] [Related]
13. A giant protease with potential to substitute for some functions of the proteasome.
Geier E; Pfeifer G; Wilm M; Lucchiari-Hartz M; Baumeister W; Eichmann K; Niedermann G
Science; 1999 Feb; 283(5404):978-81. PubMed ID: 9974389
[TBL] [Abstract][Full Text] [Related]
14. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation.
York IA; Bhutani N; Zendzian S; Goldberg AL; Rock KL
J Immunol; 2006 Aug; 177(3):1434-43. PubMed ID: 16849449
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of tripeptidyl peptidase II, a giant cytosolic protease.
Rockel B; Kopec KO; Lupas AN; Baumeister W
Biochim Biophys Acta; 2012 Jan; 1824(1):237-45. PubMed ID: 21771670
[TBL] [Abstract][Full Text] [Related]
16. Role of tripeptidyl peptidase II in MHC class I antigen presentation: Biological characteristics, cellular crosstalk and signaling.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Zang G; Tang Z
Biomed Pharmacother; 2016 Dec; 84():1954-1958. PubMed ID: 27829551
[TBL] [Abstract][Full Text] [Related]
17. In situ structural studies of tripeptidyl peptidase II (TPPII) reveal spatial association with proteasomes.
Fukuda Y; Beck F; Plitzko JM; Baumeister W
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4412-4417. PubMed ID: 28396430
[TBL] [Abstract][Full Text] [Related]
18. Tripeptidyl-peptidase II: a multi-purpose peptidase.
Tomkinson B; Lindås AC
Int J Biochem Cell Biol; 2005 Oct; 37(10):1933-7. PubMed ID: 16125107
[TBL] [Abstract][Full Text] [Related]
19. Tripeptidyl-peptidase II controls DNA damage responses and in vivo gamma-irradiation resistance of tumors.
Hong X; Lei L; Künert B; Naredla R; Applequist SE; Grandien A; Glas R
Cancer Res; 2007 Aug; 67(15):7165-74. PubMed ID: 17671184
[TBL] [Abstract][Full Text] [Related]
20. Role of tripeptidyl peptidase II in the processing of Listeria monocytogenes-derived MHC class I-presented antigenic peptides.
Grauling-Halama S; Bahr U; Schenk S; Geginat G
Microbes Infect; 2009; 11(8-9):795-802. PubMed ID: 19426827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
